Zenas BioPharma, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | -8.6% | +442.6% | +3.7% | |
| – | -12.6% | +495.1% | -1.3% | |
| – | -15.4% | +462.4% | -65.4% | |
| – | -15.4% | +516.9% | -2.2% | |
| – | +10.1% | -80.4% | +146.0% | |
| – | -10.4% | +146.3% | +9.4% | |
| – | -22.2% | +41.2% | +42.0% | |
| – | -7.2% | +217.6% | -58.5% | |
| – | – | – | – | |
| – | – | – | -22.5% | |
| – | – | – | – | |
| – | +0.0% | +9.1% | +7.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.